Talcum Powder Lawsuit Verdict Upheld in Missouri, Prompting Johnson & Johnson Appeal, Bernstein Liebhard LLP Reports

NEW YORK, Sept. 23, 2016 /PRNewswire/ -- A trial court has upheld the $55 million judgment awarded to a talcum powder lawsuit (http://www.rxinjuryhelp.com/talcum-powder/johnson-johnson-baby-powder-lawsuit/) plaintiff earlier this year. According to a September 9^th Order, the Missouri 22nd Judicial Circuit Court for St. Louis City has denied all of Johnson & Johnson's post-trial motions, including one that sought a judgment not withstanding the verdict. On September 16^th, Johnson & Johnson filed a notice of appeal. (Case No. No. 1422-CC09012-01)

Announced on May 2nd, the verdict was the second rendered this year against Johnson & Johnson in a case involving talcum powder and ovarian cancer. The 62-year-old plaintiff was diagnosed with ovarian and endometrial cancer in 2011, after having used Johnson & Johnson's Baby Powder as part of her daily feminine hygiene routine for more than 40 years. The jury awarded her $5 million in compensatory damages, and $50 million in punitive damages.

"We are pleased that the trial court has allowed this verdict to stand. Our Firm has heard from numerous women who are concerned that years of genital talcum powder use may have contributed to the development of ovarian cancer, and we are investigating a number of potential cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer following years of regular, repeated use of talc-based products for feminine hygiene purposes.

Talcum Powder Ovarian Cancer Litigation

Johnson & Johnson has been named a defendant in more than 1,000 talcum powder lawsuits involving its Baby Powder and Shower-to-Shower products. In February, another St. Louis jury awarded $72 million in compensatory and punitive damages to the family of a woman who died from ovarian cancer. Prior to her diagnosis, the plaintiff had used Johnson & Johnson talc based powders for feminine hygiene purposes for more than three decades.

Many of the pending talcum powder lawsuits have been centralized in the Missouri litigation, while additional claims have been consolidated in Atlantic County Superior Court in New Jersey. Plaintiffs pursuing federally-filed talc powder ovarian cancer claims against Johnson & Johnson have also asked that their cases be centralized in a multidistrict litigation and transferred to a single federal court for coordinated pretrial proceedings. The U.S. Judicial Panel on Multidistrict Litigation is scheduled to take up the matter at its September 29^th Hearing Session in Washington, D.C. (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation – MDL No. 2738)

Plaintiffs involved in this litigation claim that the regular and repeated application of talc-based powders to the female genitals can allow particles to enter the vagina and make their way to the ovaries. They further allege that over time, the buildup of talc can cause the type of inflammation that promotes the growth of ovarian cancer. While a number of studies published since the 1970s have suggested such a link, the lawsuits claim that Johnson & Johnson has failed to take any steps to warn women of this possible risk.

Women who were diagnosed with ovarian cancer following the long-term, regular use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author

Logo - http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com